Pentravan | 2014 In vitro drug release and Ex Vivo percutaneous absorption of Resveratrol cream using HPLC with zirconized silica stationary phase Polonini HC, de Almeida Bastos C, Leal de Oliveira MA, Azevedo da Silva CG, Hollingworth Collins C, Fernandes Brandao MA, Rezende Barbosa Raposo N Journal of Chromatography B, 947-948, 23-31 The aim of this study was to establish the profile of resveratrol permeability into and across human skin. The results show that a person using a 1g dose containing 20 mg of resveratrol will (theoretically) have 12.53 mg of it liberated into his bloodstream, gradually and continuously for 24 h. Read more SEE PRODUCT
Syrspend SF | 2013 Stability of Rifampin in SyrSpend® SF Sorenson B, Whaley P International Journal of Pharmaceutical Compounding, 17(2), 162-164 The objective of this study was to determine the stability of rifampin (25mg/ml) in SyrSpend SF. Based on data collected, the beyond-use date of the preparation is at least 60 days when refrigerated or stored at room temperature and protected from light. Read more SEE PRODUCT
Syrspend SF | 2013 Stability of Midazolam in SyrSpend® SF and SyrSpend® SF Cherry Geiger CM, Sorenson B, Whaley PA International Journal of Pharmaceutical Compounding, 17(4), 344-346 The objective of this study was to determine the stability of midazolam in SyrSpend SF and SyrSpend SF Cherry suspending agents. Based on the data collected, the beyond-use date of these preparations is at least 58 days when protected from light at both refrigerated and room temperature storage conditions. Read more SEE PRODUCT
Syrspend SF | 2013 Stability of Captopril in SyrSpend® SF Geiger CM, Sorenson B, Whaley PA International Journal of Pharmaceutical Compounding, 17(4), 336-338 The objective of this study was to determine the stability of captopril (0.8mg/ml) in SyrSpend SF suspending agent. Based on the data collected, the beyond-use date of these preparations is 14 days when protected from light and refrigerated. Read more SEE PRODUCT
Pentravan | 2013 Pulsatile administration of Testosterone by the vaginal route using Pentravan® Maia H jr, Haddad C, Maia R, França CE, Casoy J Proceedings, online In the present study, testosterone was administered in the vulval/vaginal region at a dose of 3 mg/ml dissolved in a Pentravan®. An improvement in sexuality and the sensation of well-being was reported by 88% of the patients. There was also a positive effect on vaginal atrophy. Read more SEE PRODUCT
Syrspend SF | 2012 Stability of Propranolol Hydrochloride in SyrSpend® SF Geiger CM, Voudrie MA 2nd, Sorenson B International Journal of Pharmaceutical Compounding, 16(6), 513-515 The objective of this study was to determine the stability of propranolol hydrochloride in SyrSpend SF. Based on the data collected, when protected from light at room temperature, the beyond-use date of propranolol hydrochloride in SyrSpend SF was shown to be at least 90 days. Read more SEE PRODUCT
Syrspend SF | 2012 Stability of Omeprazole in SyrSpend® SF Alka (Reconstituted) Whaley PA, Voudrie MA 2nd, Sorenson B International Journal of Pharmaceutical Compounding, 16(2), 164-166 The objective of this study was to determine the stability of omeprazole 2mg/ml in SyrSpend® SF Alka (for reconstitution). The shelf life of this product is at least 92 days, based on data collected when refrigerated and protected from light. Read more SEE PRODUCT
Syrspend SF | 2012 Stability of Vancomycin in SyrSpend® SF Whaley PA, Voudrie MA 2nd International Journal of Pharmaceutical Compounding, 16(2), 167-169 The objective of this study was to determine the stability of vancomycin (50mg/ml) in SyrSpend® SF. Based on data collected, the shelf life of this product is at least 90 days when refrigerated and protected from light. Read more SEE PRODUCT
Syrspend SF | 2012 Stability of Ursodiol in Syrspend® SF Cherry flavored Geiger CM, Voudrie MA 2nd, Sorenson B International Journal of Pharmaceutical Compounding, 16(6), 510-512 The objective of this study was to determine the stability of ursodiol (29mg/ml) in SyrSpend® SF Cherry Flavored. The beyond-use date of this product is at least 66 days, based on data collected when refrigerated and protected from light. Read more SEE PRODUCT
Syrspend SF | 2012 Stability of Gabapentin in SyrSpend® SF Sorenson B, Voudrie MA 2nd, Gehrig D International Journal of Pharmaceutical Compounding, 16(4), 347-349 The objective of this study was to determine the stability of gabapentin (50mg/ml) in SyrSpend® SF. The beyond-use date of this product is at least 90 days when refrigerated or stored at room temperature and protected from light. Based on the final potency data, the beyond-use date may be longer. Read more SEE PRODUCT